Projects per year
Personal profile
Monash teaching commitment
- Teaching pharmacokinetics and pharmacodynamics in the Bachelor of Pharmacy and postgraduate programs
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Research area keywords
- Colistin
- Polymyxin B
- Increasing Bacterial Killing
- Minimising Development of Antibiotic Resistance
- Optimising Dosing of Antibiotics
- Pharmacokinetics and Pharmacodynamics of Antibiotics
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 37 Finished
-
Developing an integrated approach to precision medicine targeting antimicrobial resistance of bacterial 'superbugs'
Landersdorfer, C. (Primary Chief Investigator (PCI)), Oliver, A. (Chief Investigator (CI)) & Nation, R. (Chief Investigator (CI))
NHMRC - National Health and Medical Research Council (Australia)
1/01/20 → 31/12/24
Project: Research
-
Combating Pseudomonas aeruginosa infections in paediatric patients with cystic fibrosis
Landersdorfer, C. (Primary Chief Investigator (PCI)), Deveson, D. (Chief Investigator (CI)), Boyce, J. (Chief Investigator (CI)), Nation, R. (Chief Investigator (CI)) & Oliver, A. (Chief Investigator (CI))
1/01/19 → 31/12/19
Project: Research
-
Overcoming multidrug-resistant hypermutable Pseudomonas aeruginosa via antibiotic combinations
Landersdorfer, C. (Primary Chief Investigator (PCI)), Oliver, A. (Chief Investigator (CI)), Harper, M. (Chief Investigator (CI)) & Nation, R. (Chief Investigator (CI))
NHMRC - National Health and Medical Research Council (Australia)
1/01/19 → 31/12/23
Project: Research
-
Targeting the Urgent Need for New Antibiotics against Gram-negative ‘Superbugs’
Li, J. (Primary Chief Investigator (PCI)), Velkov, T. (Chief Investigator (CI)), Roberts, K. (Chief Investigator (CI)), Thompson, P. (Chief Investigator (CI)) & Nation, R. (Associate Investigator (AI))
1/08/17 → 31/07/23
Project: Research
-
Targeting hypermutable 'superbugs' in chronic respiratory infections by optimised antibiotic combination dosage regimens
Landersdorfer, C. (Primary Chief Investigator (PCI)), Boyce, J. (Chief Investigator (CI)), Bulitta, J. (Chief Investigator (CI)), Nation, R. (Chief Investigator (CI)) & Oliver, A. (Chief Investigator (CI))
NHMRC - National Health and Medical Research Council (Australia)
1/01/16 → 31/12/19
Project: Research
-
Disposition of colistin in critically-ill patients on sustained low-efficiency dialysis: A population pharmacokinetic study
Boonyasiri, A., Fuhs, D. T., Naorungroj, T., Wang, L., Wang, J., Ratanarat, R., Li, J., Nation, R. L., Thamlikitkul, V. & Landersdorfer, C. B., Sept 2025, In: Clinical Microbiology and Infection. 31, 9, p. 1526-1531 6 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access1 Citation (Scopus) -
Effects of different resistance mechanisms on bacterial response to meropenem, ciprofloxacin, and their combination described by next-generation mechanism-based modelling
Terrill, A. E., Tait, J. R., Rogers, K. E., Lee, W. L., López-Causapé, C., Wang, X., Song, J., Nation, R. L., Oliver, A. & Landersdorfer, C. B., Sept 2025, In: International Journal of Antimicrobial Agents. 66, 3, 10 p., 107528.Research output: Contribution to journal › Article › Research › peer-review
Open Access -
Multiomics informed mathematical model for meropenem and tobramycin against hypermutable Pseudomonas aeruginosa
Tait, J. R., Agyeman, A. A., López-Causapé, C., Deveson-Lucas, D., Rogers, K. E., Yadav, R., Rees, V. E., Shin, B. S., Nation, R. L., Boyce, J. D., Oliver, A. & Landersdorfer, C. B., Jun 2025, In: International Journal of Antimicrobial Agents. 65, 6, 11 p., 107488.Research output: Contribution to journal › Article › Research › peer-review
Open Access -
Population Pharmacokinetic Modeling of Cefepime, Meropenem, and Piperacillin-Tazobactam in Patients With Cystic Fibrosis
Rolsma, S. L., Sokolow, A., Patel, P. C., Sokolow, K., Jimenez-Truque, N., Fissell, W. H., Ryan, V., Kirkpatrick, C. M., Nation, R. L., Gu, K., Teresi, M., Fishbane, N., Kontos, M., An, G., Winokur, P., Landersdorfer, C. B. & Creech, C. B., 15 Feb 2025, In: The Journal of Infectious Diseases. 231, 2, p. e364-e374 11 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access2 Citations (Scopus) -
Distinguishing Inducible and Non-Inducible Resistance to Colistin in Pseudomonas aeruginosa by Quantitative and Systems Pharmacology Modeling at Low and Standard Inocula
Bulitta, J. B., Shin, E., Bergen, P. J., Lang, Y., Forrest, A., Tsuji, B. T., Moya, B., Li, J., Nation, R. L. & Landersdorfer, C. B., Jan 2024, In: Journal of Pharmaceutical Sciences. 113, 1, p. 202-213 12 p.Research output: Contribution to journal › Article › Research › peer-review
3 Citations (Scopus)
Prizes
-
Australasian Pharmaceutical Science Association Medal (Distinguished Contribution to Pharmaceutical Science)
Nation, R. (Recipient), 2006
Prize: Prize (including medals and awards)
-
Elected as Life Member of Australasian Pharmaceutical Science Association
Nation, R. (Recipient), 2020
Prize: Election to learned society
-
Highly Cited Researcher (Web of Science)
Nation, R. (Recipient), 2017
Prize: National/international honour
-
Highly Cited Researcher (Web of Science)
Nation, R. (Recipient), 2016
Prize: National/international honour
-
Highly Cited Researcher (Web of Science)
Nation, R. (Recipient), 2015
Prize: National/international honour
Activities
- 1 Grant review responsibilities
-
Theme leader
Nation, R. (Member)
21 Sept 2011Activity: External Academic Engagement › Grant review responsibilities
Press/Media
-
A$9.8 million fight against superbugs
Li, J., Charman, W. N., Song, J., Purcell, A. W., Hertzog, P. J., Creek, D. J., Nation, R. L., Bullita, J. & Boyce, J. D.
24/04/14
1 Media contribution
Press/Media: Public Engagement Activities